AKT1 and urinary bladder carcinoma: We have investigated a function for autophagy in a panel of 18 bladder cancer cell lines treated with small-molecule inhibitors targeting nodes of potential therapeutic relevance: FGFR, PI3Kβ/δ, AKT and mTOR (FGFR/PTENi).